The year 2022 was quite difficult for the U.S. equity market. Major indices such as S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average fell by around 19%, 34%, and 9%, respectively, in the past year.

Despite the broad sell-off, a few stocks, such as Pinduoduo (NASDAQ: PDD) and Vertex Pharmaceuticals (NASDAQ: VRTX), managed to excel even in the difficult macroeconomic environment thanks to a solid growth story and robust financials.

Here's why these stocks continue to be smart picks even in January 2023.

Continue reading

Source Fool.com